Ozmosi | Ornidazole Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Ornidazole

Pronounced as: or-NID-uh-zole

Alternative Names: ornidazole
Clinical Status: Active
Latest Update: 2025-02-18
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral, Intravenous

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Algeria | Bangladesh | Belgium | Chile | China | Colombia | Egypt | France | India | Italy | Jordan | Korea | Luxembourg | Morocco | New Zealand | Peru | Philippines | Portugal | Russia | Sri Lanka | Switzerland | Taiwan | Turkey | Ukraine | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: CHU de Clermont-Ferrand
Company Location:
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count: 1

Recent & Upcoming Milestones

Highest Development Phases

Phase 3: Colorectal Cancer

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

2017-002542-72

 COLONPREP

P3

Active, not recruiting

Colorectal Cancer

2021-07-07

2025-06-28

Treatments

Recent News Events

Date

Type

Title

05/02/2024

PubMed

 Effect of irradiated nonionic surfactant on drug-protein binding.

05/01/2024

PubMed

 Expression of Concern: A novel hybrid construction of MnMoO4 nanorods anchored graphene nanosheets; an efficient electrocatalyst for the picomolar detection of ecological pollutant ornidazole in water and urine samples.

04/30/2024

PubMed

 Refractory pneumonia caused by Prevotella heparinolytica: a case report.

07/01/2021

News Article

 Lupin Announces FDA Approval of Supplemental New Drug Application for SOLOSEC® (secnidazole) for the Treatment of Trichomoniasis

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions